doi: 10.3389/fendo.2018.00584 Received 04 June 2018 Accepted 14 September 2018 Published 11 October 2018 Volume 9 - 2018 Edited by Gary Sweeney, York University, Canada Reviewed by Kyoung-Han Kim, University of Ottawa, Canada
Pregnancy considerations: Tirzepatide is not recommended during pregnancy, and women of childbearing potential should be advised that tirzepatide may reduce the effectiveness of oral contraceptives, particularly during initiation and dose escalation
That is, both effectively stimulate growth hormone secretion, and each one does so at a complementary rate of time release one sustained, the other immediate
GLP-1 medications are changing lives, and at TrimRx, we provide a medically supervised path to help you reach your health goals safely and effectively
Pregnancy and breastfeeding: Tirzepatide is not recommended during pregnancy and breastfeeding, and the drug should be discontinued at least one month before women attempt to conceive